U.S. Markets closed


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.000.00 (0.00%)
Full screen
Previous Close0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals6 months ago

    Philadelphia-area biotech stocks hammered in wake of Trump comments

    Philadelphia-area biotech, specialty pharmaceutical and generic drug company stocks got hammered Wednesday after President-elect Donald Trump criticized the industry for manufacturing drugs outside of the U.S. and charging excessive prices. “We’re the largest buyer of drugs in the world, but we don’t bid properly, and we’ll save billions over time and we’ll do that with a lot of other industries,” Trump said at his first news conference since July. Among the local drug company stocks taking the biggest hits Wednesday were Discovery Labs (DSCO), which dropped more than 9 percent in mid-afternoon trading, and Endo International (ENDP).

  • Zackslast year

    4 Growth Stocks to Buy Near Their 52-Week Lows

    Several investors chose to cash in at current valuations thereby triggering a sell-off and exerting downward pressure on many fundamentally attractive stocks.

  • Zacks2 years ago

    Discovery Laboratories Advances Respiratory Disease Drug

    Discovery Laboratories, Inc. (DSCO) announced that it has initiated a phase IIb study.